-
About 27 percent of Food and Drug Administration reviewers who approved hematology-oncology drugs from 2001 through 2010 left to work for the industry they previously regulated, an analysis found.
-
The Food and Drug Administration approved a muscular dystrophy drug despite deeply flawed evidence. Was the decision a dangerous precedent or flexible pragmatism reflecting patients' values?
-
The Drug Enforcement Administration is cracking down on a plant that it says is involved in a number of deaths. Advocates say kratom can help treat opioid addiction, which is a far bigger hazard.
-
The recommendations from the Food and Drug Administration represent a major expansion in testing blood for Zika. The agency had earlier advised testing only in areas with an active outbreak.
-
Drugs that consist of proteins and antibodies typically made by living organisms represent the new frontier in drug industry competition.
-
Will it be a hamburger or hummus wrap for lunch? When customers saw indications of a meal's calorie content posted online, they put fewer calories in their cart, a study finds.
-
A simplified form should make it easier for doctors to treat seriously ill patients with experimental drugs after other options run out. But that's not the only obstacle to compassionate use.
-
Most of the salt we consume is in our food before it hits the table. So the FDA is leaning on the food industry to voluntarily reduce sodium in dozens of processed foods — from bakery goods to soups.
-
Under current rules, foods containing more than 3 grams of fat per serving can't call themselves "healthy" on labels. But that excludes many foods, like Kind bars, that contain healthful nuts.
-
For its latest anti-tobacco campaign, the Food and Drug Administration wants to harness hip-hop swagger to reach minority teens — who disproportionately suffer the consequences of smoking.